文献速递淋巴瘤

霍奇金淋巴瘤患者的健康相关生活质量:德国霍奇金研究组的纵向分析

Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.
PubMed 文献 · J Clin Oncol · 2020-06-23

该研究纳入德国霍奇金研究组HD13、HD14和HD15试验中诊断时年龄18-60岁的霍奇金淋巴瘤患者,分析从诊断至治疗后5年生存期的健康相关生活质量。共分析4215例患者,发现诊断时肿瘤负荷较高与多个基线生活质量领域受损相关,生存期认知、情绪、角色、社会功能及疲劳、呼吸困难、睡眠、经济问题持续严重受影响,且不受随机化治疗影响。

要点

  • 诊断时肿瘤负荷较高与多个健康相关生活质量基线领域受损相关。
  • 生存期认知、情绪、角色、社会功能及疲劳、呼吸困难、睡眠、经济问题持续严重受影响。
  • 从第2年起,与参考值的平均偏差为12-29分,10分常被视为临床相关界值。

核心结论

  • 霍奇金淋巴瘤生存者存在大量且持续的不同健康相关生活质量缺陷,这些缺陷在很大程度上与应用化疗无关。
  • 该分析强调这些较年轻霍奇金淋巴瘤生存者在癌症经历的心理社会不良影响方面存在高度未满足的医疗需求。

研究设计与样本

  • 研究纳入德国霍奇金研究组HD13、HD14和HD15试验中诊断时年龄18-60岁的霍奇金淋巴瘤患者。
  • 使用欧洲癌症研究与治疗组织生活质量问卷C30的所有功能和症状量表分析健康相关生活质量,包括与参考值的偏差。
  • 采用多元回归和重复测量分析估计不同疾病、患者和治疗特征的影响,并计算健康相关生活质量评分的相关性。
  • 分析4215例在治疗后5年内有任何健康相关生活质量评估的患者。

主要发现

  • 诊断时肿瘤负荷较高与多个健康相关生活质量领域的基线评分受损相关。
  • 生存期认知、情绪、角色和社会功能以及疲劳、呼吸困难、睡眠和经济问题严重且持续受影响。
  • 从第2年起,与参考值的平均偏差范围为12至29分,10分是常用的临床相关界值。
  • 在所有3项试验中,治疗后2年和5年的健康相关生活质量领域显著受基线评分和年龄影响,但不受随机化治疗影响。
  • 疲劳与其他症状和量表的相关性最密切。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Many important details of health-related quality of life (HRQoL) after diagnosis and treatment of Hodgkin lymphoma (HL) are still unknown because large longitudinal studies of HRQoL are rare. Therefore, we analyzed a systematically assessed, comprehensive range of HRQoL domains in patients with HL of all stages from diagnosis up to 5 years of survivorship. PATIENTS AND METHODS: We included patients with HL age 18-60 years at diagnosis from the German Hodgkin Study Group trials HD13, HD14, and HD15. We analyzed HRQoL using all functional and symptom scales of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 including deviations from reference values. We estimated the effect of different disease, patient, and treatment characteristics using multiple regression and repeated measures analysis and computed correlations of HRQoL scores. RESULTS: We analyzed 4,215 patients with any HRQoL assessment within 5 years after treatment. Higher tumor burden at diagnosis was associated with impaired baseline scores in many HRQoL domains. During survivorship, cognitive, emotional, role, and social functioning and fatigue, dyspnea, sleep, and financial problems were severely and persistently affected. From year 2 on, mean deviations from reference values ranged between 12 and 29 points, with 10 points being a commonly used margin of clinical relevance. In all 3 trials, HRQoL domains 2 and 5 years after therapy were significantly influenced by baseline scores and age but not by randomized treatments. Fatigue was most closely correlated with other symptoms and scales. CONCLUSION: Our results show a high and persistent amount of different HRQoL deficits in survivors of HL that are largely independent of the applied chemotherapies. Our analysis underscores the high, unmet medical need of these rather young survivors of HL regarding the psychosocial adverse effects of the cancer experience.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Kreissl S, Müller H, Goergen H, et al. Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group. J Clin Oncol. 2020. PMID: 32574114. doi:10.1200/JCO.19.03160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。